Inhibition of Recruitment and Activation of Neutrophils by Pyridazinone-Scaffold-Based Compounds - Université de Reims Champagne-Ardenne Access content directly
Journal Articles International Journal of Molecular Sciences Year : 2022

Inhibition of Recruitment and Activation of Neutrophils by Pyridazinone-Scaffold-Based Compounds

Abstract

In inflammatory diseases, polymorphonuclear neutrophils (PMNs) are known to produce elevated levels of pro-inflammatory cytokines and proteases. To limit ensuing exacerbated cell responses and tissue damage, novel therapeutic agents are sought. 4aa and 4ba, two pyridazinonescaffold-based phosphodiesterase-IV inhibitors are compared in vitro to zardaverine for their ability to: (1) modulate production of pro-inflammatory mediators, reactive oxygen species (ROS), and phagocytosis; (2) modulate degranulation by PMNs after transepithelial lung migration. Compound 4ba and zardaverine were tested in vivo for their ability to limit tissue recruitment of PMNs in a murine air pouch model. In vitro treatment of lipopolysaccharide-stimulated PMNs with compounds 4aa and 4ba inhibited the release of interleukin-8, tumor necrosis factor-α, and matrix metalloproteinase-9. PMNs phagocytic ability, but not ROS production, was reduced following treatment. Using a lung inflammation model, we proved that PMNs transmigration led to reduced expression of the CD16 phagocytic receptor, which was significantly blunted after treatment with compound 4ba or zardaverine. Using the murine air pouch model, LPS-induced PMNs recruitment was significantly decreased upon addition of compound 4ba or zardaverine. Our data suggest that new pyridazinone derivatives have therapeutic potential in inflammatory diseases by limiting tissue recruitment and activation of PMNs.
Fichier principal
Vignette du fichier
Moniot et al. (2022) - Inhibition of Recruitment and Activation of Neutrophils by Pyridazinone-Scaffold-Based Compounds.pdf (3.16 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-04040084 , version 1 (21-03-2023)

Identifiers

Cite

Aurélie Moniot, Julien Braux, Renaud Siboni, Christine Guillaume, Sandra Audonnet, et al.. Inhibition of Recruitment and Activation of Neutrophils by Pyridazinone-Scaffold-Based Compounds. International Journal of Molecular Sciences, 2022, 23, ⟨10.3390/ijms23137226⟩. ⟨hal-04040084⟩
31 View
21 Download

Altmetric

Share

Gmail Facebook X LinkedIn More